WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
WuXi Biologics (2269.HK) has been named to CDP's Water Security 'A List' for the second consecutive year, recognizing its leadership in corporate transparency and water security performance. The company achieved this distinction among over 25,000 evaluated companies based on CDP's 2024 Assessment Questionnaire.
As part of its environmental initiatives, WuXi Bio launched the Water Excellence Stewardship (WES) program, supporting UN Sustainable Development Goal 6. The company has set an ambitious target to reduce water consumption intensity by 30% by 2025 compared to 2019 levels. The WES program encompasses water governance, water balance, water quality, and safe water/environmental and personal hygiene (WASH).
The company has received multiple sustainability recognitions, including an MSCI AAA Rating, EcoVadis Platinum Medal, and inclusion in the Dow Jones Sustainability Indices. As a participant in the UN Global Compact and Pharmaceutical Supply Chain Initiative, WuXi Bio continues to demonstrate leadership in environmental stewardship.
WuXi Biologics (2269.HK) è stata inserita per il secondo anno consecutivo nella 'A List' della CDP per la Sicurezza Idrica, riconoscendo la sua leadership nella trasparenza aziendale e nelle prestazioni di sicurezza idrica. L'azienda ha ottenuto questa distinzione tra oltre 25.000 aziende valutate in base al Questionario di Valutazione 2024 della CDP.
Come parte delle sue iniziative ambientali, WuXi Bio ha lanciato il programma Water Excellence Stewardship (WES), a sostegno dell'Obiettivo di Sviluppo Sostenibile 6 delle Nazioni Unite. L'azienda ha fissato un obiettivo ambizioso di ridurre l'intensità del consumo di acqua del 30% entro il 2025 rispetto ai livelli del 2019. Il programma WES comprende la governance dell'acqua, l'equilibrio idrico, la qualità dell'acqua e la sicurezza dell'acqua/igiene ambientale e personale (WASH).
L'azienda ha ricevuto numerosi riconoscimenti per la sostenibilità, tra cui un Rating MSCI AAA, la Medaglia Platino di EcoVadis e l'inclusione negli Indici di Sostenibilità di Dow Jones. Come partecipante al Global Compact delle Nazioni Unite e all'Iniziativa per la Filiera Farmaceutica, WuXi Bio continua a dimostrare leadership nella gestione ambientale.
WuXi Biologics (2269.HK) ha sido nombrada por segundo año consecutivo en la 'A List' de CDP sobre Seguridad Hídrica, reconociendo su liderazgo en transparencia corporativa y desempeño en seguridad hídrica. La empresa logró esta distinción entre más de 25,000 empresas evaluadas según el Cuestionario de Evaluación 2024 de CDP.
Como parte de sus iniciativas ambientales, WuXi Bio lanzó el programa Water Excellence Stewardship (WES), apoyando el Objetivo de Desarrollo Sostenible 6 de la ONU. La empresa se ha propuesto un objetivo ambicioso de reducir la intensidad del consumo de agua en un 30% para 2025 en comparación con los niveles de 2019. El programa WES abarca la gobernanza del agua, el equilibrio hídrico, la calidad del agua y la higiene ambiental y personal (WASH).
La empresa ha recibido múltiples reconocimientos en sostenibilidad, incluyendo una calificación MSCI AAA, la Medalla de Platino de EcoVadis y su inclusión en los Índices de Sostenibilidad de Dow Jones. Como participante en el Pacto Global de la ONU y la Iniciativa de Cadena de Suministro Farmacéutico, WuXi Bio continúa demostrando liderazgo en la gestión ambiental.
우시 바이오로직스 (2269.HK)는 CDP의 물 안전성 'A 리스트'에 2년 연속으로 선정되어 기업 투명성과 물 안전성 성과에서의 리더십을 인정받았습니다. 이 회사는 CDP의 2024 평가 질문지를 기반으로 25,000개 이상의 평가된 기업 중에서 이 영예를 차지했습니다.
환경 이니셔티브의 일환으로 우시 바이오는 유엔 지속 가능한 개발 목표 6을 지원하는 물 우수 관리(WES) 프로그램을 시작했습니다. 이 회사는 2019년 대비 2025년까지 물 소비 강도를 30% 줄이겠다는 야심찬 목표를 설정했습니다. WES 프로그램은 물 관리, 물 균형, 물 품질 및 안전한 물/환경 및 개인 위생(WASH)을 포함합니다.
이 회사는 MSCI AAA 등급, 에코바디스 플래티넘 메달 및 다우존스 지속 가능성 지수 포함 등 여러 지속 가능성 인정을 받았습니다. 유엔 글로벌 컴팩트 및 제약 공급망 이니셔티브의 참가자로서 우시 바이오는 환경 관리에서의 리더십을 계속해서 보여주고 있습니다.
WuXi Biologics (2269.HK) a été nommée pour la deuxième année consécutive dans la 'A List' de CDP pour la Sécurité de l'Eau, reconnaissant son leadership en matière de transparence d'entreprise et de performance en matière de sécurité de l'eau. L'entreprise a obtenu cette distinction parmi plus de 25 000 entreprises évaluées sur la base du Questionnaire d'Évaluation 2024 de CDP.
Dans le cadre de ses initiatives environnementales, WuXi Bio a lancé le programme Water Excellence Stewardship (WES), soutenant l'Objectif de Développement Durable 6 des Nations Unies. L'entreprise s'est fixé un objectif ambitieux de réduire l'intensité de la consommation d'eau de 30 % d'ici 2025 par rapport aux niveaux de 2019. Le programme WES englobe la gouvernance de l'eau, l'équilibre hydrique, la qualité de l'eau et l'hygiène de l'eau/environnement et personnelle (WASH).
L'entreprise a reçu de multiples reconnaissances en matière de durabilité, y compris une notation MSCI AAA, une Médaille Platine d'EcoVadis et une inclusion dans les Indices de Durabilité Dow Jones. En tant que participante au Pacte Mondial des Nations Unies et à l'Initiative de Chaîne d'Approvisionnement Pharmaceutique, WuXi Bio continue de démontrer son leadership en matière de gestion environnementale.
WuXi Biologics (2269.HK) wurde zum zweiten Jahr in Folge in die 'A List' der CDP für Wassersicherheit aufgenommen, was ihre Führungsrolle in der Unternehmens-transparenz und der Leistung im Bereich Wassersicherheit anerkennt. Das Unternehmen erreichte diese Auszeichnung unter mehr als 25.000 bewerteten Unternehmen basierend auf dem Bewertungsfragebogen 2024 der CDP.
Im Rahmen seiner Umweltinitiativen hat WuXi Bio das Programm Water Excellence Stewardship (WES) ins Leben gerufen, das das UN-Ziel für nachhaltige Entwicklung 6 unterstützt. Das Unternehmen hat sich ein ehrgeiziges Ziel gesetzt, die Wasserverbrauchsintensität bis 2025 im Vergleich zu 2019 um 30% zu reduzieren. Das WES-Programm umfasst Wasser-gouvernance, Wasserbilanz, Wasserqualität sowie sichere Wasser-/Umwelt- und persönliche Hygiene (WASH).
Das Unternehmen hat mehrere Auszeichnungen für Nachhaltigkeit erhalten, darunter eine MSCI AAA-Bewertung, die EcoVadis-Platinmedaille und die Aufnahme in die Dow Jones Nachhaltigkeitsindizes. Als Teilnehmer am UN Global Compact und an der Pharmaceutical Supply Chain Initiative zeigt WuXi Bio weiterhin Führungsstärke im Bereich Umweltverantwortung.
- Achieved CDP Water Security 'A List' rating for second consecutive year
- Received multiple high-profile ESG ratings and recognitions (MSCI AAA, EcoVadis Platinum, DJSI listing)
- Clear environmental targets with 30% water consumption reduction goal by 2025
- None.
- Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6)
- Contributing to the 2025 World Water Day campaign to ensure the availability of water and sanitation for all
According to CDP's scoring methodology, companies are evaluated on their awareness of environmental issues, management methods and advancements in environmental stewardship. Assessments are conducted across four levels that represent the steps a company moves through on its action journey: Disclosure (D-/D score), Awareness (C-/C score), Management (B-/B score), Leadership (A/A- score).
Based on data reported through the CDP 2024 Assessment Questionnaire, WuXi Biologics achieved a score of "A" for Water Security, standing out among over 25,000 companies evaluated.
As a contributor to the United Nations Sustainable Development Goal 6 (SDG6), WuXi Biologics has adopted a systematic approach to enhance environment-friendly water management and help ensure the availability of water and sanitation for all. Various proactive measures regarding water are employed: measuring, avoiding, reducing and recycling. The company has set a target to reduce water consumption intensity by
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "We are very pleased to be named once again on the CDP Water Security 'A' list, an acknowledgement that further inspires our steadfast dedication to enhancing our sustainability performance. As a global leader in Green CRDMO, we consistently deliver ESG excellence, enable partners worldwide to fulfill ESG commitments, and jointly work with all stakeholders to promote responsible practices throughout the entire value chain."
As a participant of the United Nations Global Compact (UNGC) and Pharmaceutical Supply Chain Initiative (PSCI), WuXi Biologics proactively advocates sustainability, and has earned widespread recognition for its efforts. It was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI) for two consecutive years; included in the UNGC 20 Case Examples of Sustainable Development for 20 Years Collection for its world-leading green biologics solutions; recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; merited an "A-" CDP Climate Change score; selected as a Constituent of the FTSE4Good Index Series; and listed in the Hang Seng ESG 50 Index.
About CDP
CDP is a global non-profit that runs the world's only independent environmental disclosure system. As the founder of environmental reporting, the organization believes in transparency and the power of data to drive change. Partnering with leaders in enterprise, capital, policy and science, CDP surfaces the information needed to enable Earth-positive decisions. It helped more than 24,800 companies and 1,100 cities, states and regions disclose their environmental impacts in 2024. Financial institutions with more than a quarter of the world's institutional assets use CDP data to help inform investment and lending decisions. Aligned with the ISSB's climate standard, IFRS S2, as its foundational baseline, CDP integrates best-practice reporting standards and frameworks in one place. The team is truly global, united by a shared desire to build a world where people, planet and profit are truly balanced.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
With over 12,000 skilled employees in
WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.
For more information about WuXi Biologics, please visit: www.wuxibiologics.com.
Contacts
Media
PR@wuxibiologics.com
View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-named-to-cdp-water-security-a-list-for-second-consecutive-year-302406852.html
SOURCE WuXi Biologics
FAQ
What is WuXi Biologics' (WXXWY) water consumption reduction target for 2025?
What key components are included in WuXi Biologics' Water Excellence Stewardship program?
How many companies did CDP evaluate before awarding WuXi Biologics the A rating?
What major sustainability recognitions has WuXi Biologics received recently?
